Clover Health Investments (CLOV) Share-based Compensation (2020 - 2026)

Clover Health Investments has reported Share-based Compensation for 7 years, with the latest figure at $12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 53.58% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $89.5 million (down 20.08% YoY), and the FY2025 full-year result was $103.7 million, down 9.34% from the prior year.
• Share-based Compensation for Q1 2026 stood at $12.3 million, down from $24.9 million in the prior quarter.
• The five-year high for Share-based Compensation was $42.6 million in Q3 2022, with the low at $12.3 million in Q1 2026.
• Historically, Share-based Compensation has averaged $31.5 million across 5 years, with a median of $29.6 million in 2024.
• Annual changes were most pronounced in 2022 — Share-based Compensation gained 25.38% — and 2026, when it tumbled 53.58%.
• Clover Health Investments' Share-based Compensation stood at $39.1 million in 2022, then retreated by 15.24% to $33.1 million in 2023, then decreased by 10.54% to $29.6 million in 2024, then slipped by 15.94% to $24.9 million in 2025, then tumbled by 50.76% to $12.3 million in 2026.
• The last three Share-based Compensation figures came in at $12.3 million (Q1 2026), $24.9 million (Q4 2025), and $26.1 million (Q3 2025), per Business Quant data.